ArticleTransfusion medicine (Oxford, England)2025
COVID-19 pandemic impact on blood donations and discards from screening tests for transfusion-transmitted infections in a Brazil Brazilian metropolitan area.
Article in Transfusion medicine (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Blood donation trends in Zhejiang Province, 2017-2025: an ecological study before, during, and after COVID-19.Frontiers in public health · 2026Article
- COVID-19 pandemic impact on blood donations and discards from screening tests for transfusion-transmitted infections in a Brazil Brazilian metropolitan area.Transfusion medicine (Oxford, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic posed a worldwide challenge for blood services. We aimed to evaluate the impact of the COVID-19 pandemic on blood donations and blood discards resulting from screening tests for transfused-transmitted infections (TTIs) in a Brazilian metropolitan.
methodsTime-series cohort study including data of all blood donors from January 2018 to December 2021 at the Brasília Blood Center Foundation, Federal District, Brazil. The causal impact analysis was used to evaluate the impact of COVID-19 on blood donations, and a propensity score matching was used to evaluate the effect of the COVID-19 pandemic on the seroprevalence of TTIs.
resultsThere were 205 965 blood donations during the study period. The blood donations significantly reduced soon after the onset of the COVID-19 pandemic in Brasilia, Brazil, in March 2020 until August 2020 (absolute effect per week: -2952; 95% CI: -4627 to -1355). However, from September 2020 to December 2021, blood donations had returned to the levels foreseen by the time-series model. Compared to the pre-COVID-19 period, the period between September 2020 and December 2021 was associated with a decrease of at least one reactive or indeterminate screening test for TTI (OR: 0.753, 95% CI: 0.665-0.854, p <0.001).
conclusionThere was a substantial decrease in blood donations soon after COVID-19 onset in Brazil. However, within a few months, the donation levels had returned to those projected by the model, possibly due to measures implemented by the blood centre for blood donations. The seroprevalence of TTIs decreased during the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.